Boardroom Alpha
Boardroom Alpha
EMBC · Current Report (Form 8-K) · Filed February 13, 2026

Embecta Corp — Current Report (Form 8-K)

Form
8-K
Filed
February 13, 2026
Period
Feb 11, 2026
Ticker
EMBC
Accession
0000947871-26-000153
Boardroom Alpha · Filing insights

All board nominees elected to 1-year terms; independent auditor ratified; Say-on-pay approved; equity plan amendment approved.

About Embecta Corp
Market cap
$207M
1Y TSR
−59.8%
3Y TSR
−44.3%
Board grade
C-
Sector
Healthcare
CEO
Devdatt Kurdikar
Last annual meeting: Feb 11, 2026 · View full Embecta Corp profile →

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 11, 2026

 

 

EMBECTA CORP.

(Exact name of registrant as specified in its charter)

 
Delaware
(State or Other Jurisdiction of Incorporation)
001-41186
(Commission File Number)
  87-1583942
(IRS Employer
Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey
(Address of principal executive offices)
  07054
(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000
N/A
(Former name or former address, if changed since last report)
     

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class

Trading symbol(s)

Name of each exchange
on which registered

Common Stock, par value $0.01 per share EMBC The Nasdaq Stock Market LLC (Nasdaq Global Select Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

  

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

Embecta Corp. (“embecta”) held its Annual Meeting of Stockholders on February 11, 2026 (the “2026 Annual Meeting”). The final voting results for each of the matters submitted to a vote of stockholders at the 2026 Annual Meeting are as follows:

 

Proposal No. 1: All of the Board of Directors’ nominees for director were elected to serve for a term of one year (until the 2027 annual meeting of stockholders), by the votes set forth in the table below.

 

Nominee For Against Abstain Broker Non-Vote
Carrie L. Anderson 47,769,322 693,720 63,471 4,679,180
Robert (Bob) J. Hombach 48,372,760 99,877 53,876 4,679,180
Devdatt (Dev) Kurdikar 47,928,246 542,967 55,300 4,679,180
Milton M. Morris, Ph.D. 48,370,925 103,462 52,126 4,679,180
Claire Pomeroy, M.D. 47,544,291 933,330 48,892 4,679,180
Karen N. Prange 48,197,900 266,381 62,232 4,679,180
Christopher R. Reidy 45,774,127 2,703,053 49,333 4,679,180

 

 

Proposal No. 2: The appointment of Ernst & Young LLP as embecta’s independent registered public accounting firm for fiscal year 2026 was ratified by the stockholders by the votes set forth in the table below.

For Against Abstain Broker Non-Votes
53,083,728 55,489 66,476 N/A

 

Proposal No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of embecta’s named executive officers by the votes set forth in the table below.

For Against Abstain Broker Non-Votes
47,665,209 786,816 74,488 4,679,180

 

Proposal No. 4: The stockholders approved an amendment to the Embecta Corp. 2022 Employee and Director Equity-Based Compensation Plan by the votes set forth in the table below.

 

For Against Abstain Broker Non-Votes
41,396,703 7,034,781 95,029 4,679,180

 

 

 

 

 

 

 

 

 

 

  

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 13, 2026 EMBECTA CORP.
   
By:/s/ Jeff Mann
  Jeff Mann
  Senior Vice President, General Counsel & Product Development, and Corporate Secretary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Embecta Corp (EMBC)

Reference

Frequently asked questions

When did Embecta Corp file this 8-K?
Embecta Corp (EMBC) filed this Current Report (Form 8-K) with the SEC on February 13, 2026. The accession number assigned by EDGAR is 0000947871-26-000153.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All board nominees elected to 1-year terms; independent auditor ratified; Say-on-pay approved; equity plan amendment approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Embecta Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Embecta Corp has filed under CIK 1872789, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer